Pharma Focus Asia

Adare Pharma Solutions Expands High Potency Handling Capabilities in USA and Europe


Adare Pharma Solutions plans to expand its high potency handling capabilities in the United States and Europe.


The new facility in Philadelphia, USA, spanning 128,000 square feet (12,000 square meters), is currently expanding to include a second high potency suite. This suite will provide services such as encapsulation, high-shear granulation, blending, and various other manufacturing processes.

The facility situated in Milan, Italy, covering 220,000 square feet (20,400 square metres), is scheduled for substantial enhancements within its analytical and formulation laboratories in Europe. 

These upgrades will focus on enhancing high potency capabilities and will involve the implementation of fluid bed processing, bin blending, compression, encapsulation, and pan-coating technologies.

The construction of the new suite is slated for completion by Q4 of 2024 and will complement the existing potent suite on-site, which currently offers roller compaction, milling, bin blending, and tablet compression services.

Additionally, the facility will introduce a bottle packaging line to provide comprehensive support for highly potent clinical supplies and commercial products, with operations expected to commence in Q4 of 2024.

The Vandalia facility in Ohio, covering 179,000 square feet (16,600 square meters), is currently being upgraded to enhance its R&D-to-clinical stage production suites for better handling of high potency materials. 

These upgrades will include features like dry roller compaction, microencapsulation, and fluid bed processing. 

The work is already underway and is expected to be finished by Q4 of 2024.


Name    Adare Pharma Solutions
Type      Expansion
Year      End of 2024

magazine-slider-imageMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference